| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.083 | 0.1 |